Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page
- ChecktodayChange DetectedPage revision updated from v3.4.3 to v3.5.0, a UI/metadata update that does not alter the study information.SummaryDifference0.0%

- Check8 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3, indicating a minor maintenance update.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedAdded Revision: v3.4.2. Removed the government-funding notice and the prior Revision: v3.4.1.SummaryDifference0.4%

- Check43 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operations is added, and the page will now show revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check50 days agoChange DetectedThe changes are minor UI and metadata updates: a new glossary display option, capitalization adjustments for QC-related labels, and the addition of a Revision: v3.4.0 line, replacing previous versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page.SummaryDifference0.0%

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.